Safety of Endomyocardial Biopsy in New-Onset Acute Heart Failure Requiring Veno-Arterial Extracorporeal Membrane Oxygenation.

Robert M.A. van der Boon,Wijnand K. den Dekker,Christiaan L Meuwese,Roberto Lorusso,Jan H. von der Thüsen,A. Constantinescu,Olivier C. Manintveld,Thijs Delnoij,Joris J. van der Heijden,Nicolas M. Van Mieghem,Corstiaan A. den Uil

Safety of Endomyocardial Biopsy in New-Onset Acute Heart Failure Requiring Veno-Arterial Extracorporeal Membrane Oxygenation.

2021

Robert M.A. van der Boon
Wijnand K. den Dekker
Christiaan L Meuwese
Roberto Lorusso
Jan H. von der Thüsen
A. Constantinescu
Olivier C. Manintveld
Thijs Delnoij
Joris J. van der Heijden
Nicolas M. Van Mieghem
Corstiaan A. den Uil

Background: Endomyocardial biopsy (EMB) has an important role in determining the pathogenesis of new-onset acute heart failure (new-AHF) when noninvasive testing is impossible. However, data on saf...

Keywords:

Biopsy
endomyocardial biopsy
Medicine
Internal medicine
Myocarditis
Cardiology
new onset
Heart failure
Extracorporeal membrane oxygenation
Hypertrophic cardiomyopathy
Pathogenesis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations